Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absent, accretion, Achillion, affixed, AgreementSM, al, Albireo, alfa, Annex, Apelian, Arabia, arbitrability, arbitrage, arbitration, assumption, Atkisson, batch, biochemical, blinded, border, Boston, Breaking, Bristol, bulevirtide, cap, capped, Captured, Chilean, circulate, citing, claimant, COBRA, compassionate, complaint, context, COVID, CRL, currency, dataset, decentralized, declaratory, deferral, denominated, departure, disapply, dispute, EC, eDiary, erected, Erik, Euro, exceeded, exert, explore, extinguishment, FDIC, Flagship, foreseen, foster, freely, fulltime, GlobeImmune, hearing, HTA, ILAP, inflation, Inspector, instructing, IP, Ishak, jointly, Kherson, laid, Lastly, Lending, line, LP, lt, MA, MDA, mentioned, Monday, Offshore, overhead, paired, paper, parallel, pathogenic, pause, pharmacovigilance, PharmaEssentia, PIP, placement, plaintiff, poverty, premium, proceeding, provisionally, punishable, qualitative, ratified, receivership, repaid, repayment, retaliatory, revocation, robust, Ryali, salary, satisfactorily, Saudi, SBGM, Schoen, scoring, Secretary, shareholder, Silicon, Singapore, SMBG, Sriram, stand, startup, successor, sunset, suspected, SVB, TCA, thereto, thereunder, translated, translation, underinsured, underway, unilaterally, uninsured, unusual, vaccinated, Valeant, Valley, variation, Vietnam, view, Vogenyx, Windsor, Zaporizhzhia
Removed:
Aimmune, backed, bifurcated, bind, biology, Blueprint, Byetta, chosen, conjunction, consultation, CoTherix, derivative, Dohme, drew, dulaglutide, elucidated, excluding, exemption, exenatide, FCA, Glaxo, guided, half, hedge, hundred, hyperinsulemic, illiquidity, incentivize, insignificant, InterMune, Jazz, Judge, Kline, layer, leave, LIFT, liraglutide, London, methyltranferase, mitigate, Offered, Onyx, origination, Overnight, pegylated, plasma, Prestwick, realization, refinancing, Rested, RMAT, Sharp, simplified, situation, Smith, SOFR, steering, sublicenseable, synthetic, traded, transferase, Trulicity, Trump, underwriting, underwritten, unresponsive, Upjohn, Victoza, Wellcome
Filing tables
Filing exhibits
Related press release
EIGRQ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-251497) on Form S-3 and (Nos.333-263460, 333-258509, 333-254039, 333-237156, 333-230287, 333-224872, 333-219936, 333-211009, 333-203154, 333-193662) on Form S-8 of our report dated March 16, 2023, with respect to the consolidated financial statements of Eiger BioPharmaceuticals, Inc.
/s/ KPMG LLP
San Francisco, California
March 16, 2023
March 16, 2023
KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. |